Sono-Tek (SOTK) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
28 May, 2026Market leadership and technology
Recognized as a global leader in ultrasonic spray coating systems, serving medical, electronics, alternative energy, industrial, and R&D sectors.
Proprietary ultrasonic nozzle technology enables precise, uniform, and scalable thin film coatings for diverse applications.
Technology offers significant advantages over traditional methods, including reduced overspray, lower emissions, and high repeatability.
Holds a dominant market share in ultrasonic coating equipment, with a strong reputation for innovation and reliability.
Growth strategy and business model
Focuses on disruptive, high-growth markets such as medical devices, semiconductors, clean energy, and advanced industrial applications.
Business model emphasizes full system solutions, scalable manufacturing equipment, and application engineering expertise.
Expanding product portfolio with custom-engineered, high-ASP systems tailored to customer needs.
Strategic partnerships and global distribution network support market penetration and customer engagement.
Financial performance and outlook
Achieved record revenue of $20.5M in FY 2025, representing 4% annual growth and consistent profitability.
Gross margins consistently above 45%, with zero debt since FY 2021 and strong cash position.
High-value system sales are increasing, with a 750% rise in sales over $150k since FY 2017.
Backlog reached near-record highs in 1H FY 2026, with robust demand in the medical device sector and strong momentum into FY 2027.
Latest events from Sono-Tek
- Record revenue, margin expansion, and strong medical sector growth drive robust FY 2026 results.SOTK
Q4 202628 May 2026 - Leadership in ultrasonic coatings, global reach, and scalable solutions drive growth.SOTK
Planet MicroCap Showcase: VEGAS 20253 Feb 2026 - 4% revenue growth to $20.5M, $1.27M net income, and strong backlog support near-term growth.SOTK
Q4 20253 Feb 2026 - Record backlog and clean energy demand drive double-digit first half growth and profitability.SOTK
Q2 202519 Jan 2026 - Record backlog and 50% gross margin drive 24% net income growth despite flat sales.SOTK
Q3 202613 Jan 2026 - Record backlog and high-value system sales drive growth in clean energy and tech markets.SOTK
21st Virtual Investor Summit Microcap Event13 Jan 2026 - Record revenue, 150% medical sales growth, and 50% backlog increase offset sector declines.SOTK
Q2 20267 Jan 2026 - Proxy covers director elections, auditor ratification, and executive pay, with focus on governance and oversight.SOTK
Proxy Filing1 Dec 2025 - Proxy covers director elections, auditor change, executive pay, and board governance.SOTK
Proxy Filing1 Dec 2025